High ChREBP expression was found in biopsies from NASH patients, but levels declined in patients with severe insulin resistance, indicating that ChREBP may segregate hepatic steatosis from insulin resistance [52]. Here, MLXIPL is linked to metabolic dysfunction-associated steatohepatitis.